These findings may help in further refinement of the available pharmacotherapy for KV7 - related encephalopathies, as well as for the design of new ones.
However, available research (e.g., waitlist - controlled pilot studies) suggests that behavioral / cognitive - behavioral interventions and pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) are effective for treating SM.